| scholarly article | Q13442814 |
| P953 | full work available at URL | http://cancerres.aacrjournals.org/cgi/content/abstract/51/15/4102 |
| P698 | PubMed publication ID | 1855226 |
| P2093 | author name string | Bak M | |
| Harris CC | |||
| Mandard AM | |||
| Montesano R | |||
| Welsh JA | |||
| Metcalf RA | |||
| Hollstein MC | |||
| Peri L | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esophageal neoplasm | Q56014520 |
| P304 | page(s) | 4102-4106 | |
| P577 | publication date | 1991-08-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations | |
| P478 | volume | 51 |
| Q36491931 | A preliminary study on ras protein expression in human esophageal cancer and precancerous lesions. |
| Q34498746 | Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas |
| Q36567970 | Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer |
| Q40915871 | Barrett's esophagus. The significance of p53 in clinical practice |
| Q36086081 | Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene |
| Q36809345 | Chemoprevention of esophageal squamous cell carcinoma |
| Q71972436 | Clinicopathological findings and p53 expression of thyroid cancer in children |
| Q36322862 | Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma |
| Q34098308 | Creating oral squamous cancer cells: a cellular model of oral-esophageal carcinogenesis |
| Q35498839 | DNA-protein crosslinks and p53 protein expression in relation to occupational exposure to formaldehyde |
| Q44588191 | Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor). |
| Q35560021 | Experimental Evidence for Mutagenic Potential of Duodenogastric Juice on Barrett’s Esophagus |
| Q74343761 | Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene |
| Q40588994 | Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings |
| Q36084698 | Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue |
| Q36080734 | Family history of cancer, body weight, and p53 nuclear overexpression in Duke's C colorectal cancer |
| Q36079960 | Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. |
| Q42353202 | From blood to breath: New horizons for esophageal cancer biomarkers. |
| Q26822792 | Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview |
| Q37369576 | KRAS and BRAF mutations in 203 esophageal squamous cell carcinomas: pyrosequencing technology and literature review |
| Q35471421 | Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma |
| Q40578925 | Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment |
| Q42810538 | Molecular and cellular features of esophageal cancer cells |
| Q40527903 | Multimodality treatment of cancer arising from Barrett's epithelium |
| Q35795143 | Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. |
| Q59136204 | Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome |
| Q34306782 | Specific intronicp53mutation in esophageal squamous cell carcinoma in Southern Thailand |
| Q36623678 | TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe |
| Q60919985 | Target sequencing of cancer-related genes in early esophageal squamous neoplasia resected by endoscopic resection in Japanese patients |
| Q42769520 | Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine? |
| Q62488822 | The African Esophageal Cancer Consortium: A Call to Action |
| Q42283339 | The abnormal expression of retinoic acid receptor-beta, p 53 and Ki67 protein in normal, premalignant and malignant esophageal tissues. |
| Q50486949 | The mutagenic potential of duodenoesophageal reflux. |
| Q36138664 | The relationship between smoking exposure and p53 overexpression in colorectal cancer. |
| Q41809596 | Tumourigenesis associated with the p53 tumour suppressor gene |
| Q55383452 | p53 Gene Mutations in Esophageal Cancer Detected by Polymerase Chain Reaction Single-strand Conformation Polymorphism Analysis |
| Q42755072 | p53 alterations in human squamous cell carcinomas and carcinoma cell lines |
| Q36115243 | p53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: correlation with apoptosis |
| Q42604914 | p53 point mutations in primary human gastric carcinomas |
| Q37262914 | p53 protein accumulation in oesophageal squamous cell carcinomas and precancerous lesions |
| Q55417795 | ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism |
Search more.